Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Rubio, Andrea E ^a   Abraha, Awet ^b   Carpenter, Crystal A ^b   Troyer, Ryan M ^b   Reyes Rodríguez, Ángel L ^b   Salomon, Horacio ^a   Arts, Eric J ^b   Tebit, Denis M ^b,c  

^a Universidad de Buenos Aires   (Argentina)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ARGENTINA; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; GENE IDENTIFICATION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC ORIGIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN B); HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN BF); HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; STRUCTURAL GENE; VIRAL TROPISM; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN; VPU ENV GENE; CLASSIFICATION; EPIDEMIOLOGY; GENETIC RECOMBINATION; GENETICS; HIV INFECTIONS; PATHOGENICITY; PHYSIOLOGY; VIRUS GENOME;

ARGENTINA; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; RECOMBINATION, GENETIC; VIRUS REPLICATION;

EID: 84899643335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092084     Document Type: Article

References (69)

1. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, et al. (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397: 436-441. 10.1038/17130 [doi].
2. Keele BF, Van HF, Li Y, Bailes E, Takehisa J, et al. (2006) Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313: 523-526. 1126531 [pii];10.1126/science.1126531 [doi].
3. Tebit DM, Arts EJ (2011) Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 11: 45-56. S1473-3099(10) 70186-9 [pii];10.1016/S1473-3099(10)70186-9 [doi].
4. Hemelaar J (2012) The origin and diversity of the HIV-1 pandemic. Trends Mol Med 18: 182-192. S1471-4914(11)00210-3 [pii];10.1016/j.molmed.2011.12.001 [doi].
5. Quinones-Mateu ME, Gao Y, Ball SC, Marozsan AJ, Abraha A, et al. (2002) In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms. J Virol 76: 9600-9613.
6. Bailes E, Gao F, Bibollet-Ruche F, Courgnaud V, Peeters M, et al. (2003) Hybrid origin of SIV in chimpanzees. Science 300: 1713. 10.1126/ science.1080657 [doi];300/5626/1713 [pii].
7. Tebit DM, Nankya I, Arts EJ, Gao Y (2007) HIV diversity, recombination and disease progression: how does fitness ''fit'' into the puzzle? AIDS Rev 9: 75-87.
8. Guimaraes ML, Dos Santos MA, Loureiro R, Galvao-Castro B, Morgado MG (2002) High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions. AIDS Res Hum Retroviruses 18: 1261-1269. 10.1089/088922202320886307 [doi].
9. Montano SM, Sanchez JL, Laguna-Torres A, Cuchi P, Avila MM, et al. (2005) Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr 40: 57-64. 00126334-200509010-00010 [pii].
10. Carr JK, Avila M, Gomez CM, Salomon H, Hierholzer J, et al. (2001) Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 15: F41-F47.
11. De Sa Filho DJ, Sucupira MC, Caseiro MM, Sabino EC, Diaz RS, et al. (2006) Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses 22: 1-13. 10.1089/aid.2006.22.1 [doi].
12. Ruchansky D, Casado C, Russi JC, Arbiza JR, Lopez-Galindez C (2009) Identification of a new HIV Type 1 circulating recombinant form (CRF38-BF1) in Uruguay. AIDS Res Hum Retroviruses 25: 351-356. 10.1089/aid.2008.0248 [doi].
13. Guimaraes ML, Eyer-Silva WA, Couto-Fernandez JC, Morgado MG (2008) Identification of two new CRF-BF in Rio de Janeiro State, Brazil. AIDS 22: 433-435. 10.1097/QAD.0b013e3282f47ad0 [doi];00002030-200801300-00015 [pii].
14. Sanabani SS, Pastena ER, Neto WK, Martinez VP, Sabino EC (2010) Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil. Virol J 7: 74. 1743-422X-7-74 [pii];10.1186/1743-422X-7-74 [doi].
15. Dilernia DA, Jones LR, Pando MA, Rabinovich RD, Damilano GD, et al. (2011) Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12-BF to a recombination event in the 1970s. AIDS Res Hum Retroviruses 27: 569-578. 10.1089/AID.2010.0118 [doi].
16. Gomez CM, Avila M, Hierholzer J, Pando M, Martinez PL, M et al. (2002) Mother-to-child HIV type 1 transmission in Argentina: BF recombinants have predominated in infected children since the mid-1980s. AIDS Res Hum Retroviruses 18: 477-483. 10.1089/088922202317406619 [doi].
17. Gomez-Carrillo M, Pampuro S, Duran A, Losso M, Harris DR, et al. (2006) Analysis of HIV type 1 diversity in pregnant women from four Latin American and Caribbean countries. AIDS Res Hum Retroviruses 22: 1186-1191. 10.1089/aid.2006.22.1186 [doi].
18. de Souza AC, de Oliveira CM, Rodrigues CL, Silva SA, Levi JE (2008) Short communication: Molecular characterization of HIV type 1 BF pol recombinants from Sao Paulo, Brazil. AIDS Res Hum Retroviruses 24: 1521-1525. 10.1089/ aid.2008.0089 [doi].
19. de Sa-Filho DJ, Soares MS, Candido V, Gagliani LH, Cavaliere E, et al. (2008) HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil. AIDS Res Hum Retroviruses 24: 347-353. 10.1089/ aid.2007.0203 [doi].
20. Thomson MM, Villahermosa ML, Vazquez-de-Parga E, Cuevas MT, Delgado E, et al. (2000) Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. AIDS 14: 897-899.
21. Dilernia DA, Gomez AM, Lourtau L, Marone R, Losso MH, et al. (2007) HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina. AIDS Res Hum Retroviruses 23: 1201-1207. 10.1089/aid.2007.0068 [doi].
22. Quarleri JF, Rubio A, Carobene M, Turk G, Vignoles M, et al. (2004) HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure. AIDS Res Hum Retroviruses 20: 1100-1107. 10.1089/aid.2004.20.1100 [doi].
23. Pando MA, Gomez-Carrillo M, Vignoles M, Rubio AE, dos Ramos Farias MS, et al. (2011) Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project. AIDS Res Hum Retroviruses 27: 17-23. 10.1089/ aid.2010.0013 [doi].
24. Sanabani S, Kleine NW, Kalmar EM, Diaz RS, Janini LM, et al. (2006) Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil. Infect Genet Evol 6: 368-377. S1567-1348(06) 00005-0 [pii];10.1016/j.meegid.2006.01.003 [doi].
25. Turk G, Carobene M, Monczor A, Rubio AE, Gomez-Carrillo M, et al. (2006) Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants. Retrovirology 3: 14. 1742-4690-3-14 [pii];10.1186/1742-4690-3-14 [doi].
26. Carobene MG, Rodriguez RC, De Candia CA, Turk G, Salomon H (2009) In vitro dynamics of HIV-1 BF Intersubtype Recombinants genomic regions involved in the regulation of gene expression. Virol J 6: 107. 1743-422X-6-107 [pii];10.1186/1743-422X-6-107 [doi].
27. Tebit DM, Zekeng L, Kaptue L, Salminen M, Krausslich HG, et al. (2002) Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses 18: 39-48. 10.1089/ 088922202753394709 [doi].
28. Torre VS, Marozsan AJ, Albright JL, Collins KR, Hartley O, et al. (2000) Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. J Virol 74: 4868-4876.
29. Karlsson A, Parsmyr K, Aperia K, Sandstrom E, Fenyo EM, et al. (1994) MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. J Infect Dis 170: 1367-1375.
30. Marozsan AJ, Fraundorf E, Abraha A, Baird H, Moore D, et al. (2004) Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. J Virol 78: 11130-11141. 10.1128/JVI.78.20.11130-11141.2004 [doi];78/20/ 11130 [pii].
31. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype Cinfected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160.
32. Salminen MO, Carr JK, Burke DS, McCutchan FE (1995) Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11: 1423-1425.
33. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T (2004) A webbased genotyping resource for viral sequences. Nucleic Acids Res 32: W654-W659. 10.1093/nar/gkh419 [doi];32/suppl-2/W654 [pii].
34. Schultz AK, Zhang M, Leitner T, Kuiken C, Korber B, et al. (2006) A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformatics 7: 265. 1471-2105-7-265 [pii];10.1186/1471-2105-7-265 [doi].
35. Low AJ, Swenson LC, Harrigan PR (2008) HIV coreceptor phenotyping in the clinical setting. AIDS Rev 10: 143-151.
36. Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, et al. (2009) CCR5-and CXCR4-tropic subtype C human immunodeficiency virus Type 1 isolates have a lower level pathogenic fitness than other dominant group M subtypes: Implications for the Epidemic. J Virol 83: 5592-5605. JVI.02051-08 [pii];10.1128/JVI.02051-08 [doi].
37. Tebit DM, Lobritz M, Lalonde M, Immonen T, Singh K, et al. (2010) Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to non-nucleoside RT inhibitors. J Virol. JVI.00991-10 [pii];10.1128/JVI.00991-10 [doi].
38. Arien KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, et al. (2005) Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19: 1555-1564. 00002030-200510140-00001 [pii].
39. Quinones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, et al. (2000) A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol 74: 9222-9233.
40. Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, et al. (2003) Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 77: 1021-1038.
41. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI (1994) Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 68: 6672-6683.
42. Aulicino PC, Bello G, Guimaraes ML, Ruchansky D, Rocco C, et al. (2011) Longitudinal analysis of HIV-1 BF1 recombinant strains in vertically infected children from Argentina reveals a decrease in CRF12-BF pol gene mosaic patterns and high diversity of BF unique recombinant forms. Infect Genet Evol 11: 349-357. S1567-1348(10) 00309-6 [pii];10.1016/j.meegid.2010.11.008 [doi].
43. Diaz RS, Leal E, Sanabani S, Sucupira MC, Tanuri A, et al. (2008) Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic. Virology 381: 184-193. S0042-6822(08)00530-8 [pii];10.1016/ j.virol.2008.08.014 [doi].
44. Coetzer M, Cilliers T, Ping LH, Swanstrom R, Morris L (2006) Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates. Virology 356: 95-105. S0042-6822(06)00507-1 [pii];10.1016/ j.virol.2006.07.030 [doi].
45. Clevestig P, Pramanik L, Leitner T, Ehrnst A (2006) CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop Nlinked glycosylation site. J Gen Virol 87: 607-612. 87/3/607 [pii];10.1099/ vir.0.81510-0 [doi].
46. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, Vanham G, et al. (2005) The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 79: 8979-8990. 79/14/ 8979 [pii];10.1128/JVI.79.14.8979-8990.2005 [doi].
47. Paredes R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, et al. (2009) In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine. J Virol 83: 2038-2043. JVI.02154-08 [pii];10.1128/JVI.02154-08 [doi].
48. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR (1997) The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A 94: 1925-1930.
49. Santos AF, Schrago CG, Martinez AM, Mendoza-Sassi R, Silveira J, et al. (2007) Epidemiologic and evolutionary trends of HIV-1 CRF31-BC-related strains in southern Brazil. J Acquir Immune Defic Syndr 45: 328-333. 10.1097/ QAI.0b013e3180690d6a [doi].
50. Soares MA, de Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, et al. (2003) A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 17: 11-21. 10.1097/01.aids.0000042595.93174.a4 [doi].
51. Brigido LF, Nunes CC, Oliveira CM, Knoll RK, Ferreira JL, et al. (2007) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. AIDS Res Hum Retroviruses 23: 1579-1586. 10.1089/aid.2007.0102 [doi].
52. Wang W, Jiang S, Li S, Yang K, Ma L, et al. (2008) Identification of subtype B, multiple circulating recombinant forms and unique recombinants of HIV type 1 in an MSM cohort in China. AIDS Res Hum Retroviruses 24: 1245-1254. 10.1089/aid.2008.0095 [doi].
53. Arts EJ, Quinones-Mateu ME (2003) Sorting out the complexities of HIV-1 fitness. AIDS 17: 780-781. 10.1097/01.aids.0000050881.72891.32 [doi].
54. Konings FA, Burda ST, Urbanski MM, Zhong P, Nadas A, et al. (2006) Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02-AG (CRF02-AG) has a higher in vitro replicative capacity than its parental subtypes A and G. J Med Virol 78: 523-534. 10.1002/jmv.20572 [doi].
55. Njai HF, Gali Y, Vanham G, Clybergh C, Jennes W, et al. (2006) The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02-AG) in West Central Africa may be related to its replicative fitness. Retrovirology 3: 40. 1742-4690-3-40 [pii];10.1186/1742- 4690-3-40 [doi].
56. Bello G, Aulicino PC, Ruchansky D, Guimaraes ML, Lopez-Galindez C, et al. (2010) Phylodynamics of HIV-1 circulating recombinant forms 12-BF and 38-BF in Argentina and Uruguay. Retrovirology 7: 22. 1742-4690-7-22 [pii];10.1186/1742- 4690-7-22 [doi].
57. Gomez CM, Piccardo C, Libonatti O (1992) [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina]. Rev Argent Microbiol 24: 91-101.
58. Aulicino PC, Bello G, Rocco C, Romero H, Mangano A, et al. (2007) Description of the first full-length HIV type 1 subtype F1 strain in Argentina: implications for the origin and dispersion of this subtype in South America. AIDS Res Hum Retroviruses 23: 1176-1182. 10.1089/aid.2007.0038 [doi].
59. Avila MM, Pando MA, Carrion G, Peralta LM, Salomon H, et al. (2002) Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 29: 422-426.
60. Espinosa A, Vignoles M, Carrillo MG, Sheppard H, Donovan R, et al. (2004) Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. J Acquir Immune Defic Syndr 36: 630-636. 00126334-200405010-00012 [pii].
61. Pando MA, Eyzaguirre LM, Segura M, Bautista CT, Marone R, et al. (2006) First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. Retrovirology 3: 59. 1742-4690-3-59 [pii];10.1186/1742-4690-3- 59 [doi].
62. Arien KK, Vanham G, Arts EJ (2007) Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 5: 141-151. nrmicro1594 [pii];10.1038/ nrmicro1594 [doi].
63. Anderson RM, May RM (1992) Infectious diseases of humans: dynamics and control. Oxford; New York: Oxford University Press.
64. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, et al. (2005) Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J Virol 79: 9006-9018. 79/14/9006 [pii];10.1128/ JVI.79.14.9006-9018.2005 [doi].
65. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357: 1149-1153. S0140-6736(00)04331-2 [pii];10.1016/S0140-6736(00)04331-2 [doi].
66. Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, et al. (2011) HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 25: 473-477. 10.1097/QAD. 0b013e3283437c2b [doi].
67. Wolfs TF, de Jong JJ, Van den Berg H, Tijnagel JM, Krone WJ, et al. (1990) Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc Natl Acad Sci U S A 87: 9938-9942.
68. Temereanca A, Ene L, Mehta S, Manolescu L, Duiculescu D, et al. (2013) Transmitted HIV drug resistance in treatment-naive Romanian patients. J Med Virol. 10.1002/jmv.23572 [doi].
69. Nkengasong JN, Janssens W, Heyndrickx L, Fransen K, Ndumbe PM, et al. (1994) Genotypic subtypes of HIV-1 in Cameroon. AIDS 8: 1405-1412.